Source: CounterPunch
by Dean Baker
“Ozempic sells for close to $300 for a month’s dosage in developing countries like China and India. It is expected to sell for around $15 for a month’s dosage when generics are introduced, and the price could eventually fall to around $3 when there is enough competition in the market. The price differentials in the United States and other wealthy countries are even larger. People without insurance can pay as much as $1,000 for a month’s dosage, although discounts are available that can cut this price in half. The drug still has several more years of patent protection in the United States …. With rare exceptions, drugs are cheap to manufacture and distribute; however, they can end up being expensive because governments give drug companies patent monopolies or other forms of protection.” (04/01/26)